Cargando…
Publisher Correction: TET2 is required to suppress mTORC1 signaling through urea cycle with therapeutic potential
Autores principales: | He, Jing, Lin, Mingen, Zhang, Xinchao, Zhang, Ruonan, Tian, Tongguan, Zhou, Yuefan, Dong, Wenjing, Yang, Yajing, Sun, Xue, Dai, Yue, Xu, Yue, Zhang, Zhenru, Xu, Ming, Lei, Qun-Ying, Xu, Yanping, Lv, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514300/ https://www.ncbi.nlm.nih.gov/pubmed/37735455 http://dx.doi.org/10.1038/s41421-023-00600-9 |
Ejemplares similares
-
TET2 is required to suppress mTORC1 signaling through urea cycle with therapeutic potential
por: He, Jing, et al.
Publicado: (2023) -
D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1
por: Zhang, Ruonan, et al.
Publicado: (2022) -
Publisher Correction: mTORC1 and mTORC2 Differentially Regulate Cell Fate Programs to Coordinate Osteoblastic Differentiation in Mesenchymal Stromal Cells
por: Schaub, Theres, et al.
Publicado: (2020) -
Targeting fibrinogen-like protein 1 enhances immunotherapy in hepatocellular carcinoma
por: Lin, Mingen, et al.
Publicado: (2023) -
Publisher Correction: Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma
por: Yang, Yandan, et al.
Publicado: (2022)